Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/15/2025

Calcium Channel Blocker Overdose Management

Introduction to Calcium Channel Blocker Overdose

  • Calcium channel blockers, such as amlodipine, can cause severe hypotension, bradycardia, and cardiac conduction abnormalities due to their calcium channel blocking effects, and calcium gluconate administration is used to counteract these effects by increasing extracellular calcium concentration, which helps improve myocardial contractility and blood pressure, according to the American College of Critical Care Medicine 1

Administration Guidelines

  • The American Heart Association guidelines rate calcium administration as reasonable (Class 2a, Level C-LD) for improving contractility and blood pressure in patients with calcium channel blocker poisoning 2
  • 10% Calcium Gluconate can be administered at 30-60 mL (3-6 g) IV every 10-20 minutes or as an infusion at 0.6-1.2 mL/kg/hr (0.06-0.12 g/kg/hr) 1
  • Use of central venous or secure peripheral venous access is recommended for calcium gluconate administration, and calcium gluconate is preferred over calcium chloride for peripheral administration due to less vein irritation 1
  • IV calcium administration should be followed by an infusion of 0.3 mEq/kg per hour, titrated to hemodynamic response, with monitoring of serum ionized calcium to avoid severe hypercalcemia, as recommended by the American College of Cardiology and the American Heart Association 2, 3

First-line Therapies

  • IV calcium can be used as a first-line therapy for improving contractility and blood pressure in patients with calcium channel blocker poisoning 1
  • Vasopressors, such as norepinephrine, can be used as a first-line therapy for hypotension in patients with calcium channel blocker poisoning, as recommended by the American Heart Association, starting at 2-10 mcg/min and titrating up to 100 μg/min as needed (Class 1, Level B-NR) 2
  • High-dose insulin therapy can be used as a first-line therapy for improving contractility in patients with calcium channel blocker poisoning, according to the American Heart Association, with a recommended dose of 1 U/kg IV bolus followed by 0.5-1 U/kg/hour infusion with dextrose to maintain euglycemia 1, 4

Refractory Cases

  • Atropine can be used for symptomatic bradycardia in refractory cases of calcium channel blocker poisoning, as recommended by the American Heart Association, with a dose of 0.5-1 mg IV, but treatment failures are common (Class 2a, Level C-LD) 2
  • VA-ECMO can be considered for refractory cardiogenic shock, with reported survival rates up to 77% in CCB overdose (Class 2a, Level C-LD) 2
  • Temporary cardiac pacing may be necessary for unstable bradycardia or high-grade AV block, according to the American College of Cardiology 1, 4
  • Methylene blue may be considered for refractory vasodilatory shock, but responses are mixed and effects may be transient 2
  • Glucagon may be used, with a bolus of 3-10 mg IV over 3-5 minutes and infusion of 3-5 mg/hour, but response rates are variable and vomiting is common (Class 2b, Level C-LD) 2, 5

Monitoring and Supportive Care

  • Continuous cardiac monitoring, frequent blood pressure measurements, serial monitoring of blood glucose, potassium, ionized calcium, acid-base status, and urine output are recommended for patients with calcium channel blocker toxicity, as noted by the American College of Critical Care Medicine and the American Heart Association 1, 3
  • Prolonged treatment is required due to calcium channel blocker's long half-life, and patients may need extended clinical monitoring and supportive care 2
  • Common clinical features of calcium channel blocker toxicity include hypotension, reflex tachycardia, altered mental status, pulmonary edema, ECG changes, cardiogenic shock, seizures, and metabolic acidosis 2, 6, 1
  • Delayed consideration of advanced therapies (VA-ECMO) in refractory shock can worsen outcomes, according to the American College of Critical Care Medicine and the American Heart Association 1, 4
  • Relying on conventional dialysis is ineffective for CCB removal, as stated by the American Heart Association 3
  • IV lipid emulsion therapy may be considered for refractory shock, but is not recommended for routine use due to potential increased absorption of lipophilic drugs (Class 3: No Benefit, Level C-LD) 2